Status:
COMPLETED
Individualized Exercise Oncology Program for Newly Diagnosed Breast Cancer Patients
Lead Sponsor:
Karen Wonders
Conditions:
Breast Cancer
Eligibility:
FEMALE
30-80 years
Phase:
NA
Brief Summary
To test the effect of an individualized exercise oncology program on healthcare utilization, 30-day hospital readmission, pain, and cancer treatment tolerance.
Eligibility Criteria
Inclusion
- Female; determined from electronic medical record
- Initial stage 0, 1 or 2 breast cancer diagnosis within the past 12 weeks determined from electronic medical record
- Age 30-80; determined from electronic medical record
- Physician clearance to participate in exercise
Exclusion
- Participation in supervised physical exercise within 6 months prior to study enrollment
- Currently pregnant or planning to become pregnant
- Non-English speaking
- Unable to make own medical decisions and/or to follow verbal instructions
Key Trial Info
Start Date :
August 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 28 2021
Estimated Enrollment :
251 Patients enrolled
Trial Details
Trial ID
NCT04106609
Start Date
August 23 2019
End Date
October 28 2021
Last Update
June 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maple Tree Cancer Alliance
Dayton, Ohio, United States, 45404